Insider Transactions in Q1 2023 at Inogen Inc (INGN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Bart Ben Sanford EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,673
-7.1%
|
$25,095
$15.56 P/Share
|
|
Mar 01
2023
|
Bart Ben Sanford EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,402
+16.2%
|
-
|
|
Mar 01
2023
|
Bart Ben Sanford EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,135
+9.73%
|
-
|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,012
-27.84%
|
$30,180
$15.56 P/Share
|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,470
+35.84%
|
-
|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,135
+30.5%
|
-
|
|
Mar 01
2023
|
Kristin A. Caltrider EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,231
-54.85%
|
$93,465
$15.56 P/Share
|
|
Mar 01
2023
|
Kristin A. Caltrider EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,360
+50.0%
|
-
|
|
Mar 01
2023
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,399
-20.29%
|
$50,985
$15.56 P/Share
|
|
Mar 01
2023
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,913
+33.04%
|
-
|
|
Mar 01
2023
|
George J Parr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,272
+27.35%
|
-
|
|
Mar 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,710
-23.17%
|
$55,650
$15.56 P/Share
|
|
Mar 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,556
+32.62%
|
-
|
|
Mar 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,272
+27.48%
|
-
|
|
Mar 01
2023
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
12,235
-16.66%
|
$183,525
$15.56 P/Share
|
|
Mar 01
2023
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
16,702
+28.52%
|
-
|
|
Mar 01
2023
|
Nabil Shabshab CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
7,810
+21.2%
|
-
|